Global Generic Drugs Market Size, Status and Forecast 2022
This report studies the global Generic Drugs market, analyzes and researches the Generic Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- Teva Pharma
- Novartis-Sandoz
- Mylan
- Sun Pharmaceutical
- Aspen Pharmacare
- Allergan
- Fresenius Kabi
- Pfizer (Hospira)
- Sanofi
- Aurobindo
- Lupin
- Dr. Reddy's Lab
- Apotex
- Cipla
- ENDO (Par Pharmaceutical)
- Stada
- Krka Group
- Nichi-Iko Pharmaceutical
- Valeant
- Zydus Cadila
- Hikma
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- Simple Generic Drugs
- Super Generic Drugs
- Biosimilars
- CNS
- Cardiovascular
- Genitourinary/Hormonal Drugs
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
Global Generic Drugs Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF GENERIC DRUGS
1.1 Generic Drugs Market Overview
1.1.1 Generic Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Generic Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Generic Drugs Market by Type
1.3.1 Simple Generic Drugs
1.3.2 Super Generic Drugs
1.3.3 Biosimilars
1.4 Generic Drugs Market by End Users/Application
1.4.1 CNS
1.4.2 Cardiovascular
1.4.3 Genitourinary/Hormonal Drugs
1.4.4 Respiratory
1.4.5 Rheumatology
1.4.6 Diabetes
1.4.7 Oncology
1.4.8 Others
2 GLOBAL GENERIC DRUGS COMPETITION ANALYSIS BY PLAYERS
2.1 Generic Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Teva Pharma
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Generic Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Novartis-Sandoz
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Generic Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Mylan
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Generic Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Sun Pharmaceutical
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Generic Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Aspen Pharmacare
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Generic Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Allergan
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Generic Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Fresenius Kabi
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Generic Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Pfizer (Hospira)
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Generic Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Sanofi
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Generic Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Aurobindo
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Generic Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Lupin
3.12 Dr. Reddy's Lab
3.13 Apotex
3.14 Cipla
3.15 ENDO (Par Pharmaceutical)
3.16 Stada
3.17 Krka Group
3.18 Nichi-Iko Pharmaceutical
3.19 Valeant
3.20 Zydus Cadila
3.21 Hikma
4 GLOBAL GENERIC DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Generic Drugs Market Size by Type (2012-2017)
4.2 Global Generic Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Generic Drugs in Future
4.4 Top Consumer/End Users of Generic Drugs
5 UNITED STATES GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Generic Drugs Market Size (2012-2017)
5.2 United States Generic Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Generic Drugs Market Size (2012-2017)
6.2 EU Generic Drugs Market Size and Market Share by Players (2016 and 2017)
7 JAPAN GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Generic Drugs Market Size (2012-2017)
7.2 Japan Generic Drugs Market Size and Market Share by Players (2016 and 2017)
8 CHINA GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Generic Drugs Market Size (2012-2017)
8.2 China Generic Drugs Market Size and Market Share by Players (2016 and 2017)
9 INDIA GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Generic Drugs Market Size (2012-2017)
9.2 India Generic Drugs Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Generic Drugs Market Size (2012-2017)
10.2 Southeast Asia Generic Drugs Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Generic Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Generic Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Generic Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Generic Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Generic Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Generic Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Generic Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Generic Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Generic Drugs Market Size by Application (2017-2022)
12 GENERIC DRUGS MARKET DYNAMICS
12.1 Generic Drugs Market Opportunities
12.2 Generic Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Generic Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Generic Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF GENERIC DRUGS
1.1 Generic Drugs Market Overview
1.1.1 Generic Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Generic Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Generic Drugs Market by Type
1.3.1 Simple Generic Drugs
1.3.2 Super Generic Drugs
1.3.3 Biosimilars
1.4 Generic Drugs Market by End Users/Application
1.4.1 CNS
1.4.2 Cardiovascular
1.4.3 Genitourinary/Hormonal Drugs
1.4.4 Respiratory
1.4.5 Rheumatology
1.4.6 Diabetes
1.4.7 Oncology
1.4.8 Others
2 GLOBAL GENERIC DRUGS COMPETITION ANALYSIS BY PLAYERS
2.1 Generic Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Teva Pharma
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Generic Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Novartis-Sandoz
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Generic Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 Mylan
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Generic Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Sun Pharmaceutical
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Generic Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Aspen Pharmacare
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Generic Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Allergan
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Generic Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Fresenius Kabi
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Generic Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Pfizer (Hospira)
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Generic Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Sanofi
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Generic Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Aurobindo
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Generic Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Lupin
3.12 Dr. Reddy's Lab
3.13 Apotex
3.14 Cipla
3.15 ENDO (Par Pharmaceutical)
3.16 Stada
3.17 Krka Group
3.18 Nichi-Iko Pharmaceutical
3.19 Valeant
3.20 Zydus Cadila
3.21 Hikma
4 GLOBAL GENERIC DRUGS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Generic Drugs Market Size by Type (2012-2017)
4.2 Global Generic Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Generic Drugs in Future
4.4 Top Consumer/End Users of Generic Drugs
5 UNITED STATES GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Generic Drugs Market Size (2012-2017)
5.2 United States Generic Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Generic Drugs Market Size (2012-2017)
6.2 EU Generic Drugs Market Size and Market Share by Players (2016 and 2017)
7 JAPAN GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Generic Drugs Market Size (2012-2017)
7.2 Japan Generic Drugs Market Size and Market Share by Players (2016 and 2017)
8 CHINA GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Generic Drugs Market Size (2012-2017)
8.2 China Generic Drugs Market Size and Market Share by Players (2016 and 2017)
9 INDIA GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Generic Drugs Market Size (2012-2017)
9.2 India Generic Drugs Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA GENERIC DRUGS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Generic Drugs Market Size (2012-2017)
10.2 Southeast Asia Generic Drugs Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Generic Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Generic Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Generic Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Generic Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Generic Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Generic Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Generic Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Generic Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Generic Drugs Market Size by Application (2017-2022)
12 GENERIC DRUGS MARKET DYNAMICS
12.1 Generic Drugs Market Opportunities
12.2 Generic Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Generic Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Generic Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Generic Drugs Product Scope
Figure Global Generic Drugs Market Size (Million USD) (2012-2017)
Table Global Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Generic Drugs Market Share by Regions in 2016
Figure United States Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Generic Drugs Market Share by Type in 2016
Figure Simple Generic Drugs Market Size (Million USD) and Growth Rate (2012-2017)
Figure Super Generic Drugs Market Size (Million USD) and Growth Rate (2012-2017)
Figure Biosimilars Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Generic Drugs Market Share by Application in 2016
Table Key Downstream Customer in CNS
Figure Generic Drugs Market Size (Million USD) and Growth Rate in CNS (2012-2017)
Table Key Downstream Customer in Cardiovascular
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Cardiovascular (2012-2017)
Table Key Downstream Customer in Genitourinary/Hormonal Drugs
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Genitourinary/Hormonal Drugs (2012-2017)
Table Key Downstream Customer in Respiratory
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Respiratory (2012-2017)
Table Key Downstream Customer in Rheumatology
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Rheumatology (2012-2017)
Table Key Downstream Customer in Diabetes
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Diabetes (2012-2017)
Table Key Downstream Customer in Oncology
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Oncology (2012-2017)
Table Key Downstream Customer in Others
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Generic Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Generic Drugs Market Size Share by Players in 2016
Figure Generic Drugs Market Size Share by Players in 2017
Table Teva Pharma Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Teva Pharma (2012-2017)
Figure Teva Pharma Generic Drugs Business Revenue Market Share in 2016
Table Novartis-Sandoz Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Novartis-Sandoz (2012-2017)
Figure Novartis-Sandoz Generic Drugs Business Revenue Market Share in 2016
Table Mylan Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Mylan (2012-2017)
Figure Mylan Generic Drugs Business Revenue Market Share in 2016
Table Sun Pharmaceutical Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Sun Pharmaceutical (2012-2017)
Figure Sun Pharmaceutical Generic Drugs Business Revenue Market Share in 2016
Table Aspen Pharmacare Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Aspen Pharmacare (2012-2017)
Figure Aspen Pharmacare Generic Drugs Business Revenue Market Share in 2016
Table Allergan Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Allergan (2012-2017)
Figure Allergan Generic Drugs Business Revenue Market Share in 2016
Table Fresenius Kabi Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Fresenius Kabi (2012-2017)
Figure Fresenius Kabi Generic Drugs Business Revenue Market Share in 2016
Table Pfizer (Hospira) Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Pfizer (Hospira) (2012-2017)
Figure Pfizer (Hospira) Generic Drugs Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Generic Drugs Business Revenue Market Share in 2016
Table Aurobindo Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Aurobindo (2012-2017)
Figure Aurobindo Generic Drugs Business Revenue Market Share in 2016
Table Lupin Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Lupin (2012-2017)
Figure Lupin Generic Drugs Business Revenue Market Share in 2016
Table Dr. Reddy's Lab Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Dr. Reddy's Lab (2012-2017)
Figure Dr. Reddy's Lab Generic Drugs Business Revenue Market Share in 2016
Table Apotex Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Apotex (2012-2017)
Figure Apotex Generic Drugs Business Revenue Market Share in 2016
Table Cipla Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Cipla (2012-2017)
Figure Cipla Generic Drugs Business Revenue Market Share in 2016
Table ENDO (Par Pharmaceutical) Basic Information List
Table Generic Drugs Business Revenue (Million USD) of ENDO (Par Pharmaceutical) (2012-2017)
Figure ENDO (Par Pharmaceutical) Generic Drugs Business Revenue Market Share in 2016
Table Stada Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Stada (2012-2017)
Figure Stada Generic Drugs Business Revenue Market Share in 2016
Table Krka Group Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Krka Group (2012-2017)
Figure Krka Group Generic Drugs Business Revenue Market Share in 2016
Table Nichi-Iko Pharmaceutical Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Nichi-Iko Pharmaceutical (2012-2017)
Figure Nichi-Iko Pharmaceutical Generic Drugs Business Revenue Market Share in 2016
Table Valeant Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Valeant (2012-2017)
Figure Valeant Generic Drugs Business Revenue Market Share in 2016
Table Zydus Cadila Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Zydus Cadila (2012-2017)
Figure Zydus Cadila Generic Drugs Business Revenue Market Share in 2016
Table Hikma Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Hikma (2012-2017)
Figure Hikma Generic Drugs Business Revenue Market Share in 2016
Table Global Generic Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Generic Drugs Market Size Share by Type in 2012
Figure Global Generic Drugs Market Size Share by Type in 2013
Figure Global Generic Drugs Market Size Share by Type in 2014
Figure Global Generic Drugs Market Size Share by Type in 2015
Figure Global Generic Drugs Market Size Share by Type in 2016
Figure Global Generic Drugs Market Size Share by Type in 2017
Table Global Generic Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Generic Drugs Market Size (Million USD) by Application in 2012
Figure Global Generic Drugs Market Size (Million USD) by Application in 2013
Figure Global Generic Drugs Market Size (Million USD) by Application in 2014
Figure Global Generic Drugs Market Size (Million USD) by Application in 2015
Figure Global Generic Drugs Market Size (Million USD) by Application in 2016
Figure Global Generic Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Generic Drugs
Figure United States Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Generic Drugs Market Size Share by Players in 2016
Figure United States Generic Drugs Market Size Share by Players in 2017
Figure EU Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Generic Drugs Market Size Share by Players in 2016
Figure EU Generic Drugs Market Size Share by Players in 2017
Figure Japan Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Generic Drugs Market Size Share by Players in 2016
Figure Japan Generic Drugs Market Size Share by Players in 2017
Figure China Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Generic Drugs Market Size Share by Players in 2016
Figure China Generic Drugs Market Size Share by Players in 2017
Figure India Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Generic Drugs Market Size Share by Players in 2016
Figure India Generic Drugs Market Size Share by Players in 2017
Figure Southeast Asia Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Generic Drugs Market Size Share by Players in 2016
Figure Southeast Asia Generic Drugs Market Size Share by Players in 2017
Figure Global Generic Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Generic Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Generic Drugs Market Size Share by Regions in 2017
Figure Global Generic Drugs Market Size Share by Regions in 2022
Figure United States Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Generic Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Generic Drugs Market Size Share by Type in 2017
Figure Global Generic Drugs Market Size Share by Type in 2022
Table Global Generic Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Generic Drugs Market Size (Million USD) by Application in 2017
Figure Global Generic Drugs Market Size (Million USD) by Application in 2022
Figure Generic Drugs Product Scope
Figure Global Generic Drugs Market Size (Million USD) (2012-2017)
Table Global Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Generic Drugs Market Share by Regions in 2016
Figure United States Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Generic Drugs Market Share by Type in 2016
Figure Simple Generic Drugs Market Size (Million USD) and Growth Rate (2012-2017)
Figure Super Generic Drugs Market Size (Million USD) and Growth Rate (2012-2017)
Figure Biosimilars Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Generic Drugs Market Share by Application in 2016
Table Key Downstream Customer in CNS
Figure Generic Drugs Market Size (Million USD) and Growth Rate in CNS (2012-2017)
Table Key Downstream Customer in Cardiovascular
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Cardiovascular (2012-2017)
Table Key Downstream Customer in Genitourinary/Hormonal Drugs
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Genitourinary/Hormonal Drugs (2012-2017)
Table Key Downstream Customer in Respiratory
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Respiratory (2012-2017)
Table Key Downstream Customer in Rheumatology
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Rheumatology (2012-2017)
Table Key Downstream Customer in Diabetes
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Diabetes (2012-2017)
Table Key Downstream Customer in Oncology
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Oncology (2012-2017)
Table Key Downstream Customer in Others
Figure Generic Drugs Market Size (Million USD) and Growth Rate in Others (2012-2017)
Table Generic Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Generic Drugs Market Size Share by Players in 2016
Figure Generic Drugs Market Size Share by Players in 2017
Table Teva Pharma Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Teva Pharma (2012-2017)
Figure Teva Pharma Generic Drugs Business Revenue Market Share in 2016
Table Novartis-Sandoz Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Novartis-Sandoz (2012-2017)
Figure Novartis-Sandoz Generic Drugs Business Revenue Market Share in 2016
Table Mylan Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Mylan (2012-2017)
Figure Mylan Generic Drugs Business Revenue Market Share in 2016
Table Sun Pharmaceutical Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Sun Pharmaceutical (2012-2017)
Figure Sun Pharmaceutical Generic Drugs Business Revenue Market Share in 2016
Table Aspen Pharmacare Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Aspen Pharmacare (2012-2017)
Figure Aspen Pharmacare Generic Drugs Business Revenue Market Share in 2016
Table Allergan Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Allergan (2012-2017)
Figure Allergan Generic Drugs Business Revenue Market Share in 2016
Table Fresenius Kabi Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Fresenius Kabi (2012-2017)
Figure Fresenius Kabi Generic Drugs Business Revenue Market Share in 2016
Table Pfizer (Hospira) Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Pfizer (Hospira) (2012-2017)
Figure Pfizer (Hospira) Generic Drugs Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Sanofi (2012-2017)
Figure Sanofi Generic Drugs Business Revenue Market Share in 2016
Table Aurobindo Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Aurobindo (2012-2017)
Figure Aurobindo Generic Drugs Business Revenue Market Share in 2016
Table Lupin Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Lupin (2012-2017)
Figure Lupin Generic Drugs Business Revenue Market Share in 2016
Table Dr. Reddy's Lab Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Dr. Reddy's Lab (2012-2017)
Figure Dr. Reddy's Lab Generic Drugs Business Revenue Market Share in 2016
Table Apotex Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Apotex (2012-2017)
Figure Apotex Generic Drugs Business Revenue Market Share in 2016
Table Cipla Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Cipla (2012-2017)
Figure Cipla Generic Drugs Business Revenue Market Share in 2016
Table ENDO (Par Pharmaceutical) Basic Information List
Table Generic Drugs Business Revenue (Million USD) of ENDO (Par Pharmaceutical) (2012-2017)
Figure ENDO (Par Pharmaceutical) Generic Drugs Business Revenue Market Share in 2016
Table Stada Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Stada (2012-2017)
Figure Stada Generic Drugs Business Revenue Market Share in 2016
Table Krka Group Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Krka Group (2012-2017)
Figure Krka Group Generic Drugs Business Revenue Market Share in 2016
Table Nichi-Iko Pharmaceutical Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Nichi-Iko Pharmaceutical (2012-2017)
Figure Nichi-Iko Pharmaceutical Generic Drugs Business Revenue Market Share in 2016
Table Valeant Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Valeant (2012-2017)
Figure Valeant Generic Drugs Business Revenue Market Share in 2016
Table Zydus Cadila Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Zydus Cadila (2012-2017)
Figure Zydus Cadila Generic Drugs Business Revenue Market Share in 2016
Table Hikma Basic Information List
Table Generic Drugs Business Revenue (Million USD) of Hikma (2012-2017)
Figure Hikma Generic Drugs Business Revenue Market Share in 2016
Table Global Generic Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Generic Drugs Market Size Share by Type in 2012
Figure Global Generic Drugs Market Size Share by Type in 2013
Figure Global Generic Drugs Market Size Share by Type in 2014
Figure Global Generic Drugs Market Size Share by Type in 2015
Figure Global Generic Drugs Market Size Share by Type in 2016
Figure Global Generic Drugs Market Size Share by Type in 2017
Table Global Generic Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Generic Drugs Market Size (Million USD) by Application in 2012
Figure Global Generic Drugs Market Size (Million USD) by Application in 2013
Figure Global Generic Drugs Market Size (Million USD) by Application in 2014
Figure Global Generic Drugs Market Size (Million USD) by Application in 2015
Figure Global Generic Drugs Market Size (Million USD) by Application in 2016
Figure Global Generic Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Generic Drugs
Figure United States Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Generic Drugs Market Size Share by Players in 2016
Figure United States Generic Drugs Market Size Share by Players in 2017
Figure EU Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Generic Drugs Market Size Share by Players in 2016
Figure EU Generic Drugs Market Size Share by Players in 2017
Figure Japan Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Generic Drugs Market Size Share by Players in 2016
Figure Japan Generic Drugs Market Size Share by Players in 2017
Figure China Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Generic Drugs Market Size Share by Players in 2016
Figure China Generic Drugs Market Size Share by Players in 2017
Figure India Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Generic Drugs Market Size Share by Players in 2016
Figure India Generic Drugs Market Size Share by Players in 2017
Figure Southeast Asia Generic Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Generic Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Generic Drugs Market Size Share by Players in 2016
Figure Southeast Asia Generic Drugs Market Size Share by Players in 2017
Figure Global Generic Drugs Market Size (Million USD) by Regions (2017-2022)
Table Global Generic Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Generic Drugs Market Size Share by Regions in 2017
Figure Global Generic Drugs Market Size Share by Regions in 2022
Figure United States Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Generic Drugs Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Generic Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Generic Drugs Market Size Share by Type in 2017
Figure Global Generic Drugs Market Size Share by Type in 2022
Table Global Generic Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Generic Drugs Market Size (Million USD) by Application in 2017
Figure Global Generic Drugs Market Size (Million USD) by Application in 2022
